Edit |   |
---|---|
Antigenic Specificity | HGF, Human (Ficlatuzumab biosimilar) |
Clone | Ficlatuzumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, FCM, IP, FuncS, IF, Neut |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human HGF Recombinant Antibody (Ficlatuzumab). Ficlatuzumab is a humanized monoclonal antibody designed for the treatment of cancers. Ficlatuzumab was developed by AVEO Pharmaceuticals. In May 2012, AVEO released results of a Phase II clinical trial comparing gefitinib alone and in combination with ficlatuzamab in treatment-naive Asian patients with non-small cell lung cancer. |
Immunogen | n/a |
Other Names | Anti-HGF Recombinant Antibody, Research Grade Ficlatuzumab, Anti-Human HGF Recombinant Antibody(Ficlatuzumab), AV-299, SCH 900105, Antibody Drug Analogues, Monoclonal Antibody, YR1257, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1174900-84-5 |
Catalog # | YR1257 |
Price | please inquire |
Order / More Info | HGF, Human (Ficlatuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |